CIK 0001382574 · Non-accelerated filer<br>Smaller reporting company
Scienture Holdings, Inc.
Sign in to watch- Ticker
- SCNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (800) 261 0281
- Business address
- 20 AUSTIN BLVD., COMMACK, NY, 11725
- Former names
- TRxADE HEALTH, INC, TRXADE GROUP, INC., XCELLINK INTERNATIONAL INC., Bluebird Exploration Co.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-20 | Shankar Hariharan Co-CEO & Chairman | Grant or award | +500,000 | 3,518,679 | ||
| 2026-02-20 | Narasimhan Mani President & Co-CEO | Grant or award | +500,000 | 1,550,000 | ||
| 2025-10-01 | Shankar Hariharan Co-CEO & Chairman | Grant or award | +300,000 | 3,018,679 | ||
| 2025-10-01 | Narasimhan Mani President & Co-CEO | Grant or award | +300,000 | 1,050,000 | ||
| 2025-04-14 | Shankar Hariharan Co-CEO & Chairman | Grant or award | +750,000 | 2,718,679 | ||
| 2025-04-14 | Narasimhan Mani President & Co-CEO | Grant or award | +750,000 | 750,000 | ||
| 2025-03-10 | Shankar Hariharan Co-CEO & Chairman | Other disposition | −30,000 | 1,968,679 | ||
| 2025-03-10 | Narasimhan Mani President & Co-CEO | Other disposition | −20,000 | 1,395,515 | ||
| 2024-09-19 | Shankar Hariharan Co-CEO & Chairman | Conversion | +1,916,816 | 1,998,679 | ||
| 2024-09-19 | Shankar Hariharan Co-CEO & Chairman | Conversion | +356,480 | 371,704 | ||
| 2024-09-19 | Shankar Hariharan Co-CEO & Chairman | Conversion · Series X Non-Voting Convertible Preferred Stock | −1,916,816 | 0 | ||
| 2024-09-19 | Shankar Hariharan Co-CEO & Chairman | Conversion · Series X Non-Voting Convertible Preferred Stock | −356,480 | 0 | ||
| 2024-09-19 | Narasimhan Mani President & Co-CEO | Conversion | +1,357,538 | 1,415,515 | ||
| 2024-09-19 | Narasimhan Mani President & Co-CEO | Conversion · Series X Non-Voting Convertible Preferred Stock | −1,357,538 | 0 | ||
| 2024-01-05 | AJJARAPU SURENDRA K Chairman and CEO | Grant or award | +10,000 | 82,643 | ||
| 2024-01-05 | Patel Prashant Interim CFO and Director | Grant or award | +10,000 | 112,242 | ||
| 2024-01-05 | Patel Prashant Interim CFO and Director | Grant or award | +150,000 | 150,000 | ||
| 2024-01-05 | AJJARAPU SURENDRA K Chairman and CEO | Grant or award | +150,000 | 150,000 | ||
| 2023-01-16 | PETERSON MICHAEL L Director | Grant or award | +100,000 | 118,940 | ||
| 2023-01-16 | PETERSON MICHAEL L Director | Grant or award · Stock Option | +135,802 | 135,802 |
Page 1 of 5 · 92 trades